Mosaicism of the 5q deletion as assessed by interphase FISH is a common phenomenon in MDS and restricted to myeloid cells

Leukemia

Volumn 11, Issue 4, 1997, Pages 519-523

  Kroef, M J P L ^a   Bolk, M J W ^a   Muus, P ^b   Wessels, J W ^a   Beverstock, G C ^a   Willemze, R ^a   Landegent, J E ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

5q deletion; FISH; Lineage involvement; Mosaicism

Indexed keywords

INTERLEUKIN 4;

ADULT; ARTICLE; BONE MARROW CELL; CHROMOSOME 5Q; CHROMOSOME DELETION 5; CLINICAL ARTICLE; COSMID; DNA PROBE; FEMALE; FLUORESCENCE ACTIVATED CELL SORTER; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; INTERPHASE; MARKER GENE; MONOCYTE; MOSAICISM; MYELODYSPLASTIC SYNDROME; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; YEAST ARTIFICIAL CHROMOSOME;

EID: 0030980185     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400597     Document Type: Article

References (27)

1. Mufti GJ. Chromosomal deletions in the myelodysplastic syndrome. Leuk Res 1992; 16: 35-41.
2. Van den Berghe H, Cassiman JJ, David G, Fryns JP, Michaux JL, Sokal G. Distinct hematological disorder with deletion of the long arm of No. 5 chromosome. Nature 1974; 251: 437-438.
3. Le Beau MM, Espinosa III R, Neuman WL, Stock W, Toulston D, Larson RA, Keinanen M, Westbrook CA. Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases. Proc Natl Acad Sci USA 1993; 90: 5484-5488.
4. Boultwood J, Fidler C, Lewis S, Kelly S, Sheridan H, Littlewood TJ, Buckle VJ, Wainscoat JS. Molecular mapping of uncharacteristically small 5q deletions in two patients with the 5q- syndrome: delineation of the critical region on 5q and identification of a 5q-breakpoint. Genomics 1994; 19: 425-432.
5. Cuticchia AJ, Pearson PL. Human Gene Mapping 1993. The John Hopkins University Press: Baltimore, London, 1993.
6. Willman CL, Sever CE, Pallavicini MG, Harada H, Tanaka N, Slovak ML, Yamamoto H, Harada K, Meeker TC, List AF, Taniguchi T. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science 1993; 259: 968-971.
7. Tefferi A, Thibodeau SN, Solberg LA. Clonal studies in myelodysplastic syndrome using X-linked restriction fragment length polymorphisms. Blood 1990; 75: 1770-1773.
8. van Kamp H, Fibbe WE, Jansen RPM, van der Keur M, de Graaff E, Willemze R, Landegent JE. Clonal involvement of granulocytes and monocytes, but not of T and B lymphocytes and natural killer cells in patients with myelodysplasia: analysis by X-linked restriction fragment length polymorphisms and polymerase chain reaction of the phosphoglycerate kinase gene. Blood 1992; 80: 1774-1778.
9. Gerritsen WR, Donohue J, Bauman J, Jhanwar Sc, Kernan NA, Castro-Malaspina H, O'Reilly RJ, Bourhis J-H. Clonal analysis of myelodysplastic syndrome: monosomy 7 is expressed in the myeloid lineage, but not in the lymphoid lineage as detected by fluorescent in situ hybridization. Blood 1992; 80: 217-224.
10. Kibbelaar RE, van Kamp H, Dreef EJ, Groot-Swings G, Kluin-Nelemans JC, Beverstock GC, Fibbe WE, Kluin PhM. Combined immunophenotyping and DNA in situ hybridization to study lineage involvement in patients with myelodysplastic syndromes. Blood 1992; 79: 1823-1828.
11. Kroef MJPL, Fibbe WE, Mout R, Jansen RPM, Haak HL, Wessels JW, Van Kamp H, Willemze R, Landegent JE. Myeloid but not lymphoid cells carry the 5q deletion: polymerase chain reaction analysis of loss of heterozygosity using mini-repeat sequences on highly purified cell fractions. Blood 1993; 81: 1849-1854.
12. Saltman DL, Dolganov MG, Warrington JA, Wasmuth JJ, Lovett M. A physical map of 15 loci on human chromosome 5q23-q33 by two-color fluorescence in situ hybridization. Genomics 1993; 16: 726-732.
13. Warrington JA, Bengtsson U. High-resolution physical mapping of human 5q31-q33 using three methods: radiation hybrid mapping, interphase fluorescence in situ hybridization, and pulsed-field gel electrophoresis. Genomics 1994; 24: 395-398.
14. Mankoo BS, Sherrington R, De La Concha A, Kalsi G, Curtis D, Melmer G, Curling HMD. Two microsatellite polymorphims at the D5S39 locus. Nucleic Acids Res 1991; 19: 1963.
15. Lu-Kou JM, Le Paslier D, Weissenbach J, Chumakov I, Cohen D, Ward DC. Construction of a YAC contig and a STS map spanning at least seven megabasepairs in chromosome 5q34-35. Hum Mol Genet 994; 3: 99-106.
16. Green ED, Olson MV. Systematic screening of yeast-artificial-chromosome libraries by use of the polymerase chain reaction. Proc Natl Acad Sci USA 1990; 87: 1213-1217.
17. Stock W, Chandrasekharappa SC, Neuman WL, Le Beau MM, Brownstein BH, Westbrook CA. Characterization of yeast artificial chromosomes containing interleukin genes on chromosome 5. Cytogenet Cell Genet 1992; 61: 263-265.
18. Weber JL, Polymeropoulos MH, May PE, Kwitek AE, Xiao H, McPherson JD, Wasmuth JJ. Mapping of human chromosome 5 microsatellite DNA polymorphisms. Genomics 1991; 11: 695-700.
19. Wiegant J, Galjart NJ, Raap AK, D'Azzo A. The gene encoding human protective protein (PPGB) is on chromosome 20. Genomics 1991; 10: 345-349.
20. Boultwood J, Fidler C, Lewis S, MacCarthy A, Sheridan H, Kelly S, Oscier D, Buckle VJ, Wainscoat JS. Allelic loss of IRF1 in myelodysplasia and acute myeloid leukemia: retention of IRF1 on the 5q- chromosome in some patients with the 5q- syndrome. Blood 1993; 82: 2611-2616.
21. Fairman J, Claxton D, Willman CL, Deisseroth AB, Nagarajan L. Development of a sensitive PCR to detect allele loss in a model haematopoietic neoplasm. PCR Meth Appl 1994; 4: 6-12.
22. Soenen V, Fenaux P, Flactif M, Lepelley P, Lai JL, Cosson A, Preudhomme C. Combined immunophenotyping and in situ hybridization (FICTION): a rapid method to study cell lineage involvement in myelodysplastic syndromes. Br J Haematol 1995; 90: 701-706.
23. Anastasi J, Feng J, Le Beau MM, Larson RA, Rowley JD, Vardiman JW. Cytogenetic clonality in myelodysplastic syndromes studied with fluorescence in situ hybridization: lineage, response to growth factor therapy, and clone expansion. Blood 1993; 81: 1580-1585.
24. Fugazza G, Bruzzone R, Dejana AM, Gobbi M, Ghio R, Patrone F, Rattenni S, Sessarego M. Cytogenetic clonality in chronic myelomonocytic leukemia studied with fluorescence in situ hybridization. Leukemia 1995; 9: 109-114.
25. Han K, Lee W, Harris CP, Kim W, Shim S, Meisner LF. Quantifying chromosome changes and lineage involvement in myelodysplastic syndrome (MDS) using fluorescent in situ hybridization (FISH). Leukemia 1994; 8: 81-86.
26. Busque I, Kohler S, DeHart D, Saxena R, Bernstein S, Stone R, Greenberg P, Gilliland DC. High incidence of polyclonal granulocytopoiesis in myelodysplastic syndromes (MDS). Blood 1993; 82: 196a (Abstr.).
27. Asano H, Ohashi H, Ichihara M, Kinoshita T, Murate T, Kobayashi M, Salto H, Hotta T. Evidence for nonclonal haematopoietic progenitor cell populations in bone marrow of patients with myelodysplastic syndromes. Blood 1994; 84: 588-594.